Insys Therapeutics Inc. - INSY (NASDAQ-GM)

7.73
0.21 (2.79%)
Quotes delayed 15 mins. Currently July 17, 2018 7:18:54 PM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Insys Therapeutics develops cancer support and related drugs

Key Financials

Day Range:7.41 - 7.76
52 Week Range:4.10 - 14.00
Open:7.47
Shares:73.81M
Market Cap:570.54M
EPS:-3.34
P/E Ratio:--
Div Yield:--
Performance
Previous close
No Chart Available
Purchase INSY in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of INSY not only as a single stock, but also as part of a motif.
Professional Motifs with INSY
Battling Cancer
Battling Cancer 22.7% 1 YR RTN New drugs and devices could be a game-changer for the war on the nation's second-biggest killer.
View all professional motifs with INSY
Community Motifs with INSY
BigBud Investments
BigBud Investments -- 1 YR RTN
marijuana high
marijuana high -- 1 YR RTN
Medical Marijuana
Medical Marijuana 1.6% 1 YR RTN
View all community motifs with INSY
What Others Think About INSY
1 min Stock Insights
We calculated 21-day Expected Return of $INSY for you: -6.21% unicornbay.com/t/INSY.US?utm_…
Hemp | #Followback | Legalization | #News
RT @OfficialHemp : INSYS Therapeutics, Inc. Nasdaq $INSY manufacturer of SYNDROS® a cannabinoid medicine and is the first and only FDA app…
2
Hemp | #Followback | Legalization | #News
RT @OfficialHemp : INSYS Therapeutics, Inc. Nasdaq $INSY manufacturer of SYNDROS® a cannabinoid medicine and is the first and only FDA ap…
2
Hemp | #Followback | Legalization | #News
RT @OfficialHemp : $INSY Epinephrine Nasal Spray in Development for Treatment of Anaphylaxis Shows Promise as Potential Alternative t…
1
US Consumer News
Insys Therapeutics Inc $INSY Expected to Announce Quarterly Sales of $26.67 Million zpr.io/6X8Rs
Transcript Daily
Insys Therapeutics Inc $INSY Expected to Post Earnings of -$0.15 Per Share zpr.io/6X8Pm
Enterprise Leader
Insys Therapeutics Inc $INSY Expected to Post Quarterly Sales of $26.67 Million theenterpriseleader.com/?p=990940
Related Companies Within The Biotechnology Sector
Amgen Inc. - 193.92
AMGN
GILD
Biogen Inc. - 354.98
BIIB
CELG
SHPG
Shire plc - 172.54
SHPG